Eisai
4523.T
#2243
Rank
C$11.31 B
Marketcap
C$40.09
Share price
0.95%
Change (1 day)
4.17%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.19. an increase over its 2024 EPS that were of C$1.34.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025C$1.5011.85%
2024C$1.34-32.63%
2023C$1.995.52%
2022C$1.89-74.01%
2021C$7.26-66.58%
2020C$21.7398.24%
2019C$10.9617.01%
2018C$9.3737.78%
2017C$6.80-27.62%
2016C$9.3935.33%
2015C$6.94-2.82%
2014C$7.14-27.66%
2013C$9.87-27.49%
2012C$13.62-12.67%
2011C$15.5988.08%
2010C$8.29-11.06%
2009C$9.32-390.15%
2008C-$3.21-127.78%
2007C$11.5711.78%
2006C$10.354.38%
2005C$9.917.4%
2004C$9.2343.03%
2003C$6.4525.09%
2002C$5.1652.67%
2001C$3.3869.76%
2000C$1.99